The first licensed 503A compounding pharmacy offering THC-free, prescription-only CBD in the country launched in Colorado.

Collaborative partnership enhances resources, accreditation support, and marketing opportunities for independent ...

Following the sudden cancellation, then reinstatement, of $2 billion in federal behavioral grants on January 13th and 14th, Alcohol Justice extends its appreciation to the U.S. senators and members of ...

Novo Nordisk and Eli Lilly have dominated the market until now, but this year is set to bring oral drugs, generics, and a ...

​Unfortunately, vaccines have become a party-loyalty litmus test in both the U.S. and Canada.

Amazon is closing in on a milestone that would have sounded outlandish a decade ago: becoming the first company in the United ...

Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding ...

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.

Kazmira Pharmacy operates a first-of-its-kind prescription cannabinoid (CBD) therapy platform, built for the healthcare system -- not the wellness aisle. Operating under licensed 503A pharmacy ...

This collaboration significantly expands eNavvi's capabilities, providing prescribers with streamlined access to ...